Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's disease

Inflammatory Bowel Diseases

Volumn 19, Issue 1, 2013, Pages 30-36

  Le, Quy ^a   Melmed, Gil ^a   Dubinsky, Marla ^a   Dermot McGovern, ^a   Vasiliauskas, Eric A ^a   Murrell, Zuri ^a   Ippoliti, Andrew ^a   Shih, David ^a   Kaur, Manreet ^a   Targan, Stephan ^a   Fleshner, Phillip ^a,b  

^a Inflammatory Bowel Disease Center   (United States)

^b NONE   (United States)

Author keywords

Crohn's disease; Ileal pouch anal anastomosis; Pouch failure; Surgical complications

Indexed keywords

IMMUNOMODULATING AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY; STEROID;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ANUS DISEASE; ARTICLE; CLINICAL FEATURE; COLON INJURY; COLON RESECTION; CROHN DISEASE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; FEMALE; GRANULOMA; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; ILEUS; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE BIOPSY; INTESTINE FISTULA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANCOLITIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROCTOCOLECTOMY; PROSPECTIVE STUDY; RECURRENT DISEASE; SMALL INTESTINE DISEASE; STEROID THERAPY; SURGICAL INFECTION; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; ULCERATIVE COLITIS;

EID: 84873728498     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.22955     Document Type: Article

References (22)

1. Meagher AP, Farouk R, Dozois RR, et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg. 1998;85:800-803.
2. Murrell ZA, Melmed GY, Ippoliti A, et al. A prospective evaluation of the long-term outcome of ileal pouch-anal anastomosis in patients with inflammatory bowel disease-unclassified and indeterminate colitis. Dis Colon Rectum. 2009;52:872-878.
3. Brown CJ, Maclean AR, Cohen Z, et al. Crohn's disease and indeterminate colitis and the ileal pouch-anal anastomosis: outcomes and patterns of failure. Dis Colon Rectum. 2005;48:1542-1549.
4. Reese GE, Lovegrove RE, Tilney HS, et al. The effect of Crohn's disease on outcomes after restorative proctocolectomy. Dis Colon Rectum. 2007; 50:239-250.
5. Regimbeau JM, Panis Y, Pocard M, et al. Long-term results of ileal pouch-anal anastomosis for colorectal Crohn's disease. Dis Colon Rectum. 2001;44:769-778.
6. Melton GB, Fazio VW, Kiran RP, et al. Long-term outcomes with ileal pouch-anal anastomosis and Crohn's disease: pouch retention and implications of delayed diagnosis. Ann Surg. 2008;248:608-616.
7. Shen B, Patel S, Lian L. Natural history of Crohn's disease in patients who underwent intentional restorative proctocolectomy with ileal pouch-anal anastomosis. Aliment Pharmacol Ther. 2010;31:745-753.
8. Saxon A, Shanahan F, Landers C, et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 1990;86:202-210.
9. Fleshner PR, Vasiliauskas EA, Dubinsky M, et al. Both preoperative pANCA and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis. Clin Gastroenterol Hepatol. 2008;6:561-568
10. Vasiliauskas EA, Plevy SE, Landers CJ, et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology. 1996;110:1810-1819.
11. Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiaemannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998;42:788-791.
12. Sutton CL, Yang H, Li Z, et al. Familial expression of anti-Saccharomyces cerevisiaemannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut. 2000;46:58-63.
13. Targan SR, Landers CJ, Yang H, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology. 2005;128:2020-2028.
14. Mahadeva U, Martin JP, Patel NK, et al. Granulomatous ulcerative colitis: a re-appraisal of the mucosal granuloma in the distinction of Crohn's disease from ulcerative colitis. Histopathology. 2002;41:166-168.
15. Hyde GM, Jewell DP, Kettlewell MGW, et al. Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications. Dis Colon Rectum. 2001;44:1436-1440.
16. Munoz-Juarez M, Pemberton JH, Sandborn WJ, et al. Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis. Dis Colon Rectum. 1999;42:117-120.
17. Shen B, Fazio VW, Remzi FH, et al. Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomosis. Am J Gastroenterol. 2005;100:93-101.
18. Nasseri Y, Melmed GY, Wang HL, et al. Rigorous histopathologic assessment of the colectomy specimen in patients with inflammatory bowel disease-unclassified does not predict outcome after ileal pouch-anal anastomosis. Am J Gastroenterol. 2010;105:155-161.
19. Peyregne V, Francois Y, Gilly FN, et al. Outcome of ileal pouch after secondary diagnosis of Crohn's disease. Int J Colorectal Dis. 2000;15: 49-53.
20. Melmed G, Fleshner PR, Bardakcioglu O, et al. Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum. 2008;51:100-108.
21. Shen B, Remzi FH, Brzezinski A, et al. Risk factors for pouch failure in patients with different phenotypes of Crohn's disease of the pouch. Inflamm Bowel Dis. 2008;14:942-948.
22. Melmed G, Fleshner PR, Bardakcioglu O, et al. Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum. 2008;51:100-108.